Clik here to view.
ACC 2019 Roundup: Abiomed Impella RP post-market study shows benefit in...
Abiomed (NSDQ:ABMD) today released 18-month post-approval study data from patients treated with its Impella RP, touting a benefit to survival for specifically selected “Recover Right” protocol...
View ArticleClik here to view.
ACC 2019 Roundup – ReCor touts six-month Paradise renal denervation study...
ReCor Medical this week released “on-medication” results from the RADIANCE-HTN-SOLO clinical trial of its Paradise renal denervation system intended to treat uncontrolled hypertension, touting...
View ArticleClik here to view.
Homeland Security details vulnerabilities in Medtronic ICD, CRT-Ds, CareLink...
The U.S. Dept. of Homeland Security today released a medical advisory warning of exploits within a number of Medtronic (NYSE:MDT) implanted cardiac devices and associated equipment that could allow an...
View ArticleClik here to view.
Report: Drones are delivering blood samples in N.C.
Autonomous drones have begun to ferry blood samples between clinics and labs in the skies over North Carolina, according to a recent report from Wired. The drone service, run by UPS with drone...
View ArticleClik here to view.
Medtronic touts stroke data for HeartWare LVAD
A retrospective analysis of two studies involved the HeartWare left-ventricular assist device Medtronic (NYSE:MDT) acquired in 2016 showed that managing blood pressure reduced the severity of strokes...
View ArticleClik here to view.
Medtronic touts economic data for HeartWare HVAD
Medtronic (NYSE:MDT) today touted more data on the HeartWare left-ventricular assist device it acquired in 2016, saying economic analyses of prior trials showed its cost effectiveness. The Fridley,...
View Article